Clinical trial
Effect of Remifentanil on Electroencephalographic BAR Index During Propofol…
NCT00455026 · Melbourne Health, Other · Completed
Key facts
| NCT number | NCT00455026 |
|---|---|
| Title | Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia |
| Official title | Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia |
| Lead sponsor | Melbourne Health, Other |
| Collaborators | Biopharmica Limited Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Depth of Anaesthesia |
| Intervention type | Drug |
| Interventions | remifentanil |
| Enrollment | 45 |
| Start date | Mar 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Apr 3, 2007 |
| Last update posted | May 30, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: